By presenting the time-specific involvement of diverse purinergic receptors in the disease progression, we will discuss their relevance for the development of new more powerful diagnostic and therapeutic avenues for amyotrophic lateral sclerosis. This evidence concerns the gene P2RX6 and amyotrophic lateral sclerosis.